October 9, 2026

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amidst Biotechnology Innovation

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) sits at the intersection of biotechnology and innovation, offering a compelling yet challenging landscape for investors. As a trailblazer in..

REGENXBIO Inc. (RGNX) Investor Outlook: Unpacking a 191.51% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with a promising prospect for investors seeking substantial growth potential. This clinical-stage company, headquartered in Rockville,..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Biotech’s Potential with an 8.65% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands at the intersection of biotechnology and innovation, offering investors a unique opportunity within the healthcare sector. With a market..

EyePoint, Inc. (EYPT) Stock Analysis: Uncovering a Potential 648.82% Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is catching the attention of investors with a staggering potential upside of 648.82%, according to analyst ratings. Despite its current challenges, this..

AtaiBeckley Inc. (ATAI) Stock Analysis: An Insight into the Biotech Innovator’s 10.43% Potential Upside

AtaiBeckley Inc. (NASDAQ: ATAI) presents a compelling opportunity for investors seeking exposure to the innovative and rapidly evolving field of mental health treatments. With its robust..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 263% Upside in the Biotech Arena

Humacyte, Inc. (NASDAQ: HUMA) is capturing the attention of investors with its groundbreaking biotechnology solutions and a remarkable potential upside of 263.45%. As a pioneer in..

Standard BioTools Inc. (LAB): Investor Outlook on a Potential 101% Upside in Medical Devices

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with a promising potential upside of..

RxSight, Inc. (RXST) Stock Analysis: Potential 56% Upside and Strategic Position in Medical Devices

RxSight, Inc. (NASDAQ: RXST) is capturing the attention of investors with its cutting-edge technology in the healthcare sector, specifically within the medical devices industry. Based in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges in the Diagnostics & Research Sector

For investors keeping a close eye on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents both challenges and potential opportunities. Operating in the diagnostics and..

Capricor Therapeutics (CAPR) Stock Analysis: Exploring a Potential 237.08% Upside in the Biotech Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is emerging as a noteworthy player in the biotechnology sector, particularly for investors seeking exposure to innovative healthcare solutions. With a..

Cronos Group Inc. (CRON) Stock Analysis: Strong Revenue Growth but Analysts Cautious with Target Ratings

Cronos Group Inc. (NASDAQ: CRON), a major player in the healthcare sector and a notable member of the specialty and generic drug manufacturers industry, is drawing..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Potential Upside and Strategic Collaborations Drive Investor Interest

Nurix Therapeutics, Inc. (NRIX), a clinical-stage biopharmaceutical company, has captured the attention of investors with its promising drug pipeline and strategic collaborations with industry giants. With..

Relay Therapeutics, Inc. (RLAY): Navigating Biotech Innovation with a 58% Upside Potential

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with its innovative approach to drug discovery focused on precision medicine. With a market cap..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring an 82.45% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector with its promising pipeline of immunology-based therapies. As a clinical-stage biopharmaceutical company, Zenas is..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 41.97% Potential Upside in the Healthcare Sector

Butterfly Network, Inc. (NYSE: BFLY) has been capturing investor attention with its innovative approach to ultrasound imaging solutions. As a prominent player in the healthcare sector,..

Kamada Ltd. (KMDA) Stock Analysis: A 73.63% Potential Upside in the Healthcare Sector

Kamada Ltd. (KMDA), a prominent player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to the drug manufacturing industry, particularly in specialty..

Septerna, Inc. (SEPN) Stock Analysis: A 46.94% Potential Upside in the Biotech Sector

Septerna, Inc. (NASDAQ: SEPN) is making waves in the biotechnology industry, capturing the attention of individual investors with a potential upside of 46.94%. As a clinical-stage..

Prothena Corporation plc (PRTA) Stock Analysis: Navigating the 148% Potential Upside with Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA) is an intriguing player in the biotech arena, particularly for investors with an appetite for high-risk, high-reward opportunities. With its headquarters..

AngioDynamics, Inc. (ANGO) Stock Analysis: Unpacking the 78% Potential Upside

For investors eyeing the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) offers an intriguing opportunity. This medical technology company, headquartered in Latham, New York, specializes in innovative..

Auna SA (AUNA)

⚠️ No article content returned.

..
Search

Funds

October 9, 2026

Search

Funds

October 9, 2026

FTSE 100

Funds